Press Releases
STAG INDUSTRIAL TO PARTICIPATE IN NAREIT CONFERENCE
BOSTON, Nov. 12, 2026 /PRNewswire/ -- STAG Industrial, Inc. (the "Company") (NYSE:STAG) announced today that it will be participating in NAREIT's REITworld 2026 Annual Conference the week of November 16, 2026. In advance of the upcoming conference, the Company has provided a refreshed investor presentation as well as a business update presentation on its website (www.stagindustrial.com) under the "Presentations" tab in the Investor Relations section...
Caliber Reports Third Quarter 2026 Financial Results
2026 Revenue Guidance Revised, Platform Profitability Guidance Reaffirmed; Three Additional Offerings Tokenized
Wolf Popper LLP Announces Investigation on Behalf of Ionis Pharmaceuticals, Inc. Investors
NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of purchasers of Ionis Pharmaceuticals, Inc. (Ionis) common stock (NASDAQ: IONS).
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2027 ended September 30, 2026 and Provides Conference Call Information
Conference Call Scheduled for Friday, November 13, 2026 at 11:30 AM EST Northvale, New Jersey--(Newsfile Corp. - November 12, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced results for the Second quarter of fiscal year 2027 ended September 30, 2026 ("Second Quarter"). Consolidated revenues for the three-month period ending September 30, 2026, were $40.1 million, an increase of $3.8 million or approximately 10.4% as compared to the same period of the prior fiscal year...
3D Systems Celebrates 40 Years During Formnext 2026
The inventor of 3D printing to highlight the history and the future of 3D printing at key industry trade show Recognition for the early innovators across the industry who helped build the additive industry Visit booth D11 in Hall 11 at Formnext to see new developments in MultiJet 3D printing, Direct Metal 3D printing and more. ROCK HILL, S.C...
Eledon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Planned global Phase 3 LEGACY trial of tegoprubart in kidney transplantation remains on track to initiate in Q4 2026 FDA cleared the Company's IND application for a planned registrational path study of tegoprubart in islet cell transplantation for patients with type 1 diabetes FDA Fast Track designation granted to tegoprubart for the prevention of rejection in kidney transplantation Cash, cash equivalents and short-term investments of $69.7 million with cash runway into Q2 2027 IRVINE, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today reported its third quarter 2026 operating and financial results and provided recent business highlights...
Sinclair Advances DINOCARE® Fuel Platform With TOP TIERTM + Approved Gasoline
SALT LAKE CITY--(BUSINESS WIRE)--Sinclair Oil (Sinclair), an HF Sinclair (NYSE and NYSE Texas, Inc.: DINO) brand, is taking the next step in its commitment to fuel quality with the rollout of Sinclair fuel with DINOCARE, a TOP TIERTM+ approved gasoline, building on the TOP TIERTM approved gasoline customers know today. The transition to TOP TIERTM+ strengthens Sinclair's established DINOCARE fuel platform with enhanced fuel quality and engine cleanliness benefits, giving drivers even more con...
MDU Resources Announces Quarterly Dividend on Common Stock
BISMARCK, N.D., Nov. 12, 2026 /PRNewswire/ -- The board of directors of MDU Resources Group, Inc. (NYSE: MDU) today declared a quarterly dividend on the company's common stock of 14.5 cents per share, unchanged from the previous quarter.
Gates Introduces Compact ThermalCool™ 2100SS Pump to Expand Data Center Portfolio
4U-Compatible Design Delivers High Performance for AI and High-Density Computing Applications DENVER, Nov. 12, 2026 /PRNewswire/ -- Gates Industrial Corporation Ltd. (NYSE: GTES), a global manufacturer of highly engineered power transmission and fluid power solutions, today introduced Gates ThermalCool™ 2100SS Pump, expanding the company's portfolio of liquid-cooling solutions for AI and high-density data center applications...
Zhengye Biotechnology Holding Limited Announces Financial Results for the First Six Months of Fiscal Year 2026
JILIN, China, Nov. 12, 2026 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today announced its unaudited financial results for the six months ended June 30, 2026. Mr. Songlin Song, co-chief executive officer of Zhengye, remarked, "During the first half of fiscal year 2026, we continued to enhance profitability through disciplined cost management and operational efficiency...
Aethlon Medical Reports Second Quarter Fiscal 2027 Results and Provides Corporate Update
SAN DIEGO, Nov. 12, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a clinical-stage medical therapeutic company, today announced financial results for fiscal second quarter ended September 30, 2026, and provided a corporate update. Corporate Updates Merger On September 17, 2026, we entered into a Plan of Merger and Reorganization (the "Merger Agreement") with North Immunology, Inc. ("North Immunology") and two wholly owned subsidiaries of the Company, pursuant to which the parties agreed to effect a two-step merger transaction (the "Merger")...
WYNDHAM HOTELS & RESORTS DECLARES QUARTERLY CASH DIVIDEND
PARSIPPANY, N.J., Nov. 12, 2026 /PRNewswire/ -- Wyndham Hotels & Resorts, Inc. (NYSE: WH) announced today its Board of Directors declared a quarterly cash dividend of $0.43 per share on its common stock, payable December 30, 2026 to shareholders of record as of December 15, 2026.
Azitra, Inc. Announces Q3 2026 Results and Provides Business Updates
BRANFORD, Conn., Nov. 12, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology and high value cosmetic proteins and peptides, today reported financial results for the quarter ended September 30, 2026, and provided a business update...
Health In Tech Reports Third Quarter 2026 Financial Results
Contracted Revenue of $32.7 Million for the First Nine Months of 2026 Pipeline Revenue of $156.4 Million as of October 30, 2026 Distribution Partners Grew 15.9% Year Over Year STUART, Fla., Nov. 12, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced its unaudited financial results for the third quarter ended September 30, 2026...
Battalion Oil Corporation Announces Third Quarter 2026 Financial and Operating Results
HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the third quarter of 2026. Key Q3 2026 Highlights Generated third quarter 2026 sales volumes of 11,359 barrels of oil equivalent per day (“Boe/d”) (~43% oil, 69% liquids) Ended the quarter with $92.1 million of cash and cash equivalents and net debt (term loan indebtedness less cash and cash equivalents) of $70.4 million, down from $74.2 million at June 30, 2026 and $163.3 million at September 30, 2025...
Aeluma Announces First Quarter Fiscal 2027 Financial Results
Continued Progress in Technology Readiness for AI Datacom Market Executed Purchase Agreement With Aixtron for MOCVD Capacity Expansion and Large-Diameter Wafer Manufacturing GOLETA, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU) (“Aeluma” or the “Company”), a semiconductor company specializing in high-performance, scalable technologies for AI, mobile and consumer, defense and aerospace, and quantum, today reported financial results for its first quarter of fiscal 2027 ended September 30, 2026...
Prairie Operating Co. Announces Third Quarter 2026 Results
HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Prairie Operating Co. (Nasdaq: PROP) (the “Company,” “Prairie,” “we,” “our,” or “us”) – an independent energy company engaged in the development and acquisition of oil, natural gas, and natural gas liquids (“NGL”) resources in the Denver-Julesburg (DJ) Basin – today announced its financial and operational results for the quarter ended September 30, 2026...
Gemini Reports Third Quarter 2026 Results
Total revenue of $40.9 million, with services revenue and interest income at 59% of net revenue as platform spot trading volume declined 73% year-over-year; total operating expenses decreased 30% year-over-year Total revenue of $40.9 million, with services revenue and interest income at 59% of net revenue as platform spot trading volume declined 73% year-over-year; total operating expenses decreased 30% year-over-year
Spire Increases Common Stock Dividend
24th Consecutive Year of Increases ST. LOUIS, Nov. 12, 2026 /PRNewswire/ -- The board of directors of Spire Inc. (NYSE: SR) unanimously agreed to increase the annual common stock dividend to $3.46 per share from $3.30 per share.
Live Oak Bancshares, Inc. Closes Depositary Share Offering
WILMINGTON, N.C., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE: LOB) (“Live Oak” or the “Company”) announced the closing of its previously announced underwritten offering of 4,000,000 depositary shares, each representing a 1/40th interest in a share of its 8.750% Fixed Rate Series B Non-Cumulative Perpetual Preferred Stock (the “Series B Preferred Stock”), with a liquidation preference of $25 per depositary share. As a result of the public offering, Live Oak received proceeds of approximately $96,250,000, net of estimated expenses and underwriting discounts and commissions...
Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights
– STRO-004, TF-targeting ADC, Phase 1 STRIVE-01 study advancing; next clinical update and initiation of expansion cohorts planned first half of 2027 –
Standard Lithium Reports Third Quarter 2026 Results
VANCOUVER, British Columbia, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, today announced its financial and operating results for the three- and nine-month periods ended September 30, 2026...
Correction to the Annual General Meeting Venue Address
TOKYO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- CTW (Nasdaq: CTW) ("CTW" or "the Company"), a leading game platform company providing global access to web-based games through its flagship platform, G123.jp, today announced a correction to the venue address for its annual general meeting as stated in the Company's press release, notice of annual general meeting and form of proxy furnished with its Report on Form 6-K on November 9, 2026...
Praxis Precision Medicines Details Launch Readiness for Relutrigine and Ulixacaltamide and Outlines Expanded Pipeline in Preparation to be the Preeminent CNS Biotech at Investor Day
Detailed launch readiness for relutrigine and ulixacaltamide, with PDUFA target action dates of December 27, 2026 and January 29, 2027
New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
Submission is based on Phase 3 REZILIENT3 data in first-line EGFR ex20ins NSCLC Submission is based on Phase 3 REZILIENT3 data in first-line EGFR ex20ins NSCLC
YD Bio Announces FDA Grant of INTERACT Meeting Request for YDB-LMSCEV-001, an Investigational Extracellular Vesicle Candidate for Dry Eye Disease
FDA agrees to provide written guidance by January 4, 2027, to support development of YDB-LMSCEV-001 TAIPEI, Taiwan, Nov. 12, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection and ophthalmologic innovations, today announced that the U.S. Food and Drug Administration (the “FDA”) has granted its request for an INTERACT (INitial Targeted Engagement for Regulatory Advice on CBER/CDER ProducTs) meeting. Through this program, the FDA will provide early written regulatory feedback on YDB-LMSCEV-001, the Company's investigational biologic eye drop for moderate-to-severe dry eye disease...
WhiteHawk Minerals Corp. Announces $45.5 Million of Acquisitions, Third Quarter 2026 Results, and Quarterly Dividend
PHILADELPHIA--(BUSINESS WIRE)--WhiteHawk Minerals Corp. (NYSE: WHK) (“WhiteHawk” or the “Company”) today announced the signing of $45.5 million of natural gas mineral and royalty acquisitions since August 13, 2026, as well as operating and financial results for the third quarter ended September 30, 2026. WhiteHawk will host a conference call and webcast to discuss its results for the third quarter of 2026 on November 13, 2026 at 9:00 a.m. Eastern Time. Third Quarter 2026 and Recent Highlights S...
DiaMedica Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (“DiaMedica” or the “Company”) (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia (PE), fetal growth restriction (FGR) and acute ischemic stroke (AIS), today provided a business update and reported financial results for the third quarter ended September 30, 2026. Management will host a conference call Friday, November 13, 2026, at 8:00 AM Eastern Time / 7:00 AM Central Time...
Veradermics to Present at the Jefferies Global Healthcare Conference in London
NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced that company management will present at the Jefferies Global Healthcare Conference in London on Thursday, November 19, 2026, at 8:30 a.m. GMT / 3:30 a.m. EST. A live webcast of the presentation will be available on the “Events” page of the “Investors” section of the Company's...
PHINIA Board Declares Quarterly Dividend of $0.30 per Common Share
AUBURN HILLS, Mich.--(BUSINESS WIRE)--PHINIA Inc. (NYSE: PHIN), a diversified industrial supplier and global leader in the development of fuel systems, electrical systems, and aftermarket solutions, today announced that its Board of Directors has declared a quarterly cash dividend in the amount of $0.30 per common share, payable on December 11, 2026, to shareholders of record at the close of business on November 23, 2026. About PHINIA PHINIA is a diversified industrial supplier and global leade...
ExxonMobil Advances Next Phase of Guyana Development with Longtail
SPRING, Texas--(BUSINESS WIRE)--ExxonMobil advances the Longtail development offshore Guyana, adding future production capacity and supporting economic growth.
Robinhood Markets, Inc. Reports October 2026 Operating Data
MENLO PARK, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for October 2026.
Hour Loop Reports Results for Three and Nine Months Ended September 30, 2026
Continued Profitability Despite a Challenging Economic Environment Redmond, WA, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Hour Loop, Inc. (NASDAQ: HOUR) (“Hour Loop” or the “Company”), a leading online retailer, announces its financial and operational results for the three and nine months ended September 30, 2026. Financial Highlights for Three and Nine Months Ended September 30, 2026: · Net revenues for the third quarter of 2026 decreased 4% to $32.1 million, compared to $33.4 million in the year-ago period; · Net income for the third quarter of 2026 decreased to $0.4 million, compared to $0.5 million in the year-ago period; · For the nine months ended September 30, 2026, net revenues increased 11% to $95.9 million, compared to $86.4 million in the year-ago period; · Net income for the nine months ended September 30, 2026 decreased to $2.3 million, compared to $2.4 million for the year-ago period; and · Cash used in operating activities for the nine months ended September 30, 2026 was $4.1 million, compared to $0.4 million in the year-ago period...
Lulus Reports Third Quarter 2026 Results
CHICO, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Lulu's Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (Nasdaq: LVLU) today reported financial results for the third quarter ended September 27, 2026, revised its financial outlook for the fiscal year ending January 3, 2027 and provided its financial outlook for the fiscal year ending January 2, 2028...
authID Reports Financial and Operating Results for the Third Quarter 2026
DENVER, Nov. 12, 2026 (GLOBE NEWSWIRE) -- authID (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today reported financial and operating results for the quarter ended September 30, 2026.
Laird Superfood Reports Third Quarter 2026 Financial Results
BOULDER, Colo.--(BUSINESS WIRE)-- #coffee--Laird Superfood, Inc. (NYSE American: LSF) (“Laird Superfood,” the “Company”, “we”, and “our”), today reported financial results for the third quarter ended September 30, 2026. Jason Vieth, Chief Executive Officer, commented, “Q3 was our first full quarter operating Laird Superfood, Navitas Organics, and Terrasoul Superfoods as one platform. Net sales grew 225% to $42.0 million, and Adjusted EBITDA reached $2.1 million as we began capturing synergies. We remain...
York Space Systems Reports Third Quarter 2026 Results
DENVER--(BUSINESS WIRE)---- $YSS--York Space Systems shares Q3 2026 earnings.
flyExclusive and Fly Alliance Announce Strategic Agreement to Integrate Flight Operations, Aircraft Management and Maintenance
RALEIGH, N.C. & ORLANDO, Fla.--(BUSINESS WIRE)--flyExclusive, Inc. (NYSE American: FLYX), one of the nation's largest private jet operators, and Fly Alliance, an established private aviation provider, today announced a management services agreement under which flyExclusive will provide flight operations, aircraft management, maintenance support and related business services for Fly Alliance. The agreement will bring approximately eight Fly Alliance aircraft onto flyExclusive's operating platfor...
Xos Extends Gross Profit Streak, Highlighting Operational Efficiency
Recorded third consecutive quarter of positive GAAP gross profit: nine-month GAAP gross margin expanded to 26.9% from 13.3% in the prior year Reduced nine-month operating expenses by 10.0%, narrowing nine-month GAAP and non-GAAP operating losses by 13.9% and 34.5%, respectively Grew revenue 17.0% and improved adjusted EBITDA 15.6% sequentially LOS ANGELES, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Xos, Inc. (NASDAQ: XOS) ("Xos" or the "Company"), a leading energy storage and fleet electrification solutions provider, today reported financial results for the third quarter ended September 30, 2026. Building on a year of disciplined execution and consistent operational improvement, Xos recorded its third consecutive quarter of positive gross profit and reduced its operating expenses both year-over-year and sequentially, showcasing the durability of its operating model and its commitment to operational efficiency...
Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
– Independent Safety Monitoring Committee recommended advancement of SER-252 in Parkinson's disease to Cohort 2 – Dosing initiated in Cohort 2 of the registrational study ; topline single-ascending-dose data expected in the first half of 2027 –
Sempra Completes Sale of 45% Equity Interest in Sempra Infrastructure Partners
SAN DIEGO, Nov. 12, 2026 /PRNewswire/ -- Sempra (NYSE: SRE) today announced the successful close of its previously announced sale of a 45% equity interest in Sempra Infrastructure Partners (SI Partners) to affiliates of KKR, a leading global investment firm, with indirect co-investor Canada Pension Plan Investment Board. "This marks an exciting milestone at Sempra," said Jeffrey W...
Chime to Participate in UBS Global Technology and AI Conference
SAN FRANCISCO--(BUSINESS WIRE)--Chime (Nasdaq: CHYM) announced today that CEO and Co-founder Chris Britt will participate in a fireside chat at the UBS Global Technology and AI Conference in Scottsdale, AZ, on Wednesday, December 2, 2026 at 12:15 p.m. Mountain Standard Time (11:15 a.m. Pacific Time). A live webcast of the fireside chat will be accessible on Chime's Investor Relations website at investors.chime.com. A replay will be available for a limited period of time following the conferenc...
BioCardia Reports Third Quarter 2026 Business Highlights and Financial Results
SUNNYVALE, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the third quarter 2026 and filed its quarterly report on Form 10-Q for the three and nine months ended September 30, 2026 with the Securities and Exchange Commission. The Company will also hold a conference call at 4:30 PM ET today in which it will discuss business highlights. Following management's formal remarks, there will be a question-and-answer session...
MultiSensor AI Announces Third Quarter 2026 Results
Alpharetta, Georgia--(Newsfile Corp. - November 12, 2026) - MultiSensor AI Holdings, Inc. (NASDAQ: MSAI) (the "Company", "MultiSensor AI" or "MSAI") today announced financial results for the third quarter ended September 30, 2026. Asim Akram, Chief Executive Officer, said, "Our relationship with our largest distribution customer shows how we believe this business scales...
Laminar Joins Rockwell Automation PartnerNetwork to Advance Productive and Sustainable Manufacturing
Collaboration brings Laminar's real-time fluid intelligence together with Rockwell's industrial automation capabilities to optimize Clean-in-Place processes, recover production capacity and reduce resource use BOSTON, Nov. 12, 2026 /PRNewswire/ -- Laminar, creator of Process-Aware Autonomy and the foundation that makes self-driving factories possible, today announced that it has joined the Rockwell Automation PartnerNetwork™ as a Technology Partner, expanding access to its real-time fluid intelligence for manufacturers using Rockwell Automation technologies. The collaboration will focus on helping manufacturers optimize Clean-in-Place (CIP) and product changeover processes while advancing both operational performance and sustainability objectives...
Verrica Pharmaceuticals Reports Third Quarter 2026 Financial Results
– Company reports record U.S. YCANTH net product revenue of $5.7 million in Q3 2026, up 11.9% over the previous quarter and 57.9% year-over-year, and total revenue of $6.9 million –
COPT Defense Declares Fourth Quarter 2026 Common Dividend
COLUMBIA, Md.--(BUSINESS WIRE)--COPT Defense Properties (NYSE: CDP) (“COPT Defense” or the “Company”) announced today that its Board of Trustees declared a regular quarterly dividend of $0.32 per common share for the fourth quarter ending December 31, 2026. The fourth quarter 2026 dividend represents an annualized amount of $1.28 per share and is payable on January 15, 2027, to shareholders of record on December 31, 2026. About COPT Defense COPT Defense, an S&P MidCap 400 Company, is a self...
Zefiro Methane Reports First Quarter Fiscal 2027 Financial Results
Revenue Rose 31% Sequentially to $12.1 Million as the Acquired Viking Fleet Continues to Scale Bradford, Pennsylvania--(Newsfile Corp. - November 12, 2026) - Zefiro Methane Corp. (CBOE CA: ZEFI) (FSE: Y6B) (OTCQB: ZEFIF) (the "Company", "Zefiro", or "ZEFI"), a North American environmental services company specializing in the maintenance, remediation, and plugging of orphaned and end-of-life oil and gas wells for methane abatement, has reported its financial results for the first quarter of fiscal 2027 ended September 30, 2026. All figures are presented in U.S. dollars unless otherwise noted...
Nektar Therapeutics Announces Third Quarter 2026 Financial Results
SAN FRANCISCO, Nov. 12, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced its financial results for the third quarter ended September 30, 2026, and provided a business update. Cash and investments in marketable securities on September 30, 2026, were $952.9 million as compared to $245.8 million on December 31, 2025...
Marpai Reports Third Quarter 2026 Financial Results
Marpai Returns to Revenue Growth in Third Quarter 2026, Achieving First Year-Over-Year and Sequential Increase Since 2023 Integrated TPA and PBM Offering and AI-Powered Claims Automation Position Company for Next Phase of Growth $12.1 Million Series A Preferred Financing Funds Strategic Investments TAMPA, Fla., Nov. 12, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology-driven provider of Third-Party Administration ("TPA"), Pharmacy Benefit Management ("PBM"), and integrated health plan services, today announced its financial and operational results for the three and nine months ended September 30, 2026...
Realty Income Announces Chief Strategy Officer Transition
SAN DIEGO, Nov. 12, 2026 /PRNewswire/ -- Realty Income Corporation (Realty Income, NYSE: O), The Monthly Dividend Company, today announced that its Executive Vice President and Chief Strategy Officer, and President of Realty Income International, Neil Abraham, will be leaving the company. To ensure a smooth transition, Mr...
BIO GREEN MED SOLUTION REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
KUALA LUMPUR, MALAYSIA, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; "BGMS" or the "Company"), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced third quarter financial results and provided a business update...
Energous Wireless Power Solutions Reports Third Quarter 2026 Results
– Third Quarter Revenue Increases 167% Year over Year, Continuing Streak of Consecutive Quarterly Growth – Year-to-Date Revenue Exceeds Full-Year 2025 Results – Conference Call Today at 4:30 p.m. Eastern Time
InspireMD Announces Proposed Public Offering
MIAMI, Nov. 12, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced that it has commenced a proposed public offering of (i) shares of its common stock, (ii) in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock, and (iii) accompanying common warrants to purchase shares of its common stock or pre-funded warrants in lieu thereof to purchase shares of its common stock. All securities in the proposed offering are being offered by InspireMD...
Pyxis Tankers Agrees to Sell Pyxis Karteria at an Expected $21.0 Million Gain $37.0 million sale price expected to generate a gain of approximately $2.05 per share and support fleet expansion and renewal
Maroussi, Greece – November 12, 2026 – Pyxis Tankers Inc. (Nasdaq Capital Market: PXS) (the “Company” or “Pyxis Tankers”), an international shipping company, today announced that it has entered into an agreement to sell the Pyxis Karteria, a 46,652 dwt MR product tanker built in 2013 at Hyundai Mipo, to an unaffiliated buyer for a sale price of $37.0 million...
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
CAMBRIDGE, Mass., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of its underwritten public offering of 41,071,428 shares of its common stock, which includes the full exercise of the underwriters' option to purchase 5,357,142 additional shares of its common stock, at a public offering price of $3.50 per share. All of the shares of common stock in the offering were sold by Prime Medicine. The gross proceeds to Prime Medicine from the offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $143.7 million...
Anaptys Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
SAN DIEGO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with Tesaro, a GSK company, and Quimilza (imsidolimab) with Vanda, today reported financial results for the fiscal first quarter ended September 30, 2026, and provided a business update...
Voting Rights and Shares Capital of the Company
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)
FinWise Bancorp Announces Increase in Share Repurchase Program
MURRAY, Utah, Nov. 12, 2026 (GLOBE NEWSWIRE) -- FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), parent company of FinWise Bank (the “Bank”), today announced that its Board of Directors has authorized an additional 600,000 shares of the Company's common stock that may be repurchased pursuant to its repurchase program. The program was originally approved by the Board on May 19, 2026, to purchase up to 685,000 shares, or approximately 5% of issued and outstanding shares...
Morningstar Research Projects Universal Automated Savings Policies Could Improve Retirement-Income Adequacy
CHICAGO--(BUSINESS WIRE)--Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment insights, today released “From Access to Adequacy: Modeling Universal Automated Savings,” a new analysis from Morningstar's Center for Retirement & Policy Studies examining how federal savings policies could help more Americans prepare financially for retirement. Researchers used Morningstar's Model of U.S. Retirement Outcomes to evaluate a combined policy scenario reflecting ideas under...
Docebo Announces Participation in Upcoming Investor Conferences in November
TORONTO--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO, TSX: DCBO), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop, announced today that members of its management team will present at the following investor and software industry conferences in November 2026: 7th Annual Needham Virtual Tech Week - November 18th & 19th - Virtual TD Cowen 18th Annual Canadian Technology Conference, November 23th - Toronto For more informa...
Nakamoto Reports Third Quarter 2026 Financial and Operating Results
NASHVILLE, Tenn.--(BUSINESS WIRE)--Nakamoto Inc. (NASDAQ: NAKA) (“Nakamoto” or the “Company”), a Bitcoin company that owns and operates a portfolio of Bitcoin-native enterprises, today announced its financial and operating results for the third quarter ended September 30, 2026. David Bailey, Chairman and Chief Executive Officer of Nakamoto, said, “We spent the third quarter building. We launched Bitcoin Magazine TV to add year-round sponsorship revenue, took UTXO into structured credit, and hel...
Nakamoto Extends Maturity of Kraken Loan
NASHVILLE, Tenn.--(BUSINESS WIRE)--Nakamoto Inc. (NASDAQ: NAKA) (“Nakamoto” or the “Company”), a Bitcoin company that owns and operates a portfolio of Bitcoin-native enterprises, today announced that its wholly owned subsidiary, Nakamoto Holdings Inc., has amended its loan agreement with Payward Interactive, Inc. (“Kraken”) to extend the maturity of 60 million USDT of the 165 million USDT outstanding principal amount of the loan from December 4, 2026, to December 4, 2027. Following the amendmen...
Agilent to Participate in 9th Annual Evercore Healthcare Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the company will participate in the upcoming 9th Annual Evercore Healthcare Conference. Agilent management is scheduled to participate in a fireside chat from 10 a.m. to 10:50 a.m. EST on Tuesday, Dec. 1, 2026, in Coral Gables, Florida. A live audio webcast and replay of the presentation will be available through Agilent's Investor Relations website. About Agilent Technologies Agilent Technologies Inc...
VICI Properties Inc. Announces New $500 Million 5-Year Unsecured Term Loan
NEW YORK--(BUSINESS WIRE)--VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”) today announced that its subsidiary issuer, VICI Properties L.P. (“VICI LP”), has closed on an amendment to its existing credit agreement, which added a new $500 million unsecured term loan (the “Term Loan”). The Term Loan matures on January 31, 2032 and initially bears interest at SOFR plus 90 basis points, based on a pricing grid tied to VICI LP's current credit ratings, and includes a pricing im...
Farmer Mac Declares Quarterly Dividends on Common and Preferred Stock
WASHINGTON, Nov. 12, 2026 /PRNewswire/ -- The Board of Directors of the Federal Agricultural Mortgage Corporation (Farmer Mac) has declared a fourth quarter dividend of $1.60 per share for each of Farmer Mac's three classes of common stock – Class A Voting Common Stock (NYSE: AGM.A), Class B Voting Common Stock (not listed on any exchange), and Class C Non-Voting Common Stock (NYSE: AGM). The quarterly dividend will be payable on December 31, 2026 to holders of record of common stock as of December 15, 2026...
Andersen Group Reports Third Quarter Revenue Growth of 18.7% to $337.3 Million
SAN FRANCISCO--(BUSINESS WIRE)--Andersen Group Inc. today reported strong financial results for the third quarter, with revenue increasing 18.7% to $337.3 million.
Net Power Reports Third Quarter 2026 Results and Provides Business Update
HOUSTON--(BUSINESS WIRE)--Net Power Inc. (NYSE: NPWR) (“Net Power” or the “Company”) today announced its financial and operational results for the third quarter ended September 30, 2026. “This past quarter, we recalibrated our strategy to what data center customers need today and over the next decade: fast, reliable, and scalable power. Our power solution is being designed to deliver exactly that, and, just as important, our focus on co-located configurations is intended to let us serve that de...
Intellinetics Reports Improved Third-Quarter Profitability and Gross Margin Expansion
COLUMBUS, Ohio--(BUSINESS WIRE)--Intellinetics, Inc. (NYSE American: INLX), a digital transformation solutions provider, announced financial results for the three and nine months ended September 30, 2026. 2026 Third Quarter Financial Highlights Software as a Service (SaaS) revenue increased 5.0% year over year to $1.7 million. Total revenue increased 0.7% year over year to $4.0 million, driven by growth in SaaS and storage and retrieval revenue. Professional services revenue decreased 2.5% year...
Coursera to Participate in the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Coursera to Participate in the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference.
KinderCare Reports Third Quarter 2026 Financial Results
LAKE OSWEGO, Ore.--(BUSINESS WIRE)--KinderCare Reports Third Quarter 2026 Financial Results.
Hexis Capital Management to Transfer NICO ETF Listing to the Texas Stock Exchange on November 25, 2026
NICO is the first actively managed ETF to combine tobacco and nicotine sector investing with a structured engagement program DALLAS and LONDON, Nov. 12, 2026 /PRNewswire/ -- Hexis Capital Management ("Hexis"), adviser to the Hexis Active Nicotine Engagement ETF (NYSE Arca: NICO), today announced that it will transfer the actively managed exchange-traded fund primary listing from NYSE Arca to the Texas Stock Exchange ("TXSE"). Shares are expected to begin trading on TXSE on November 25, 2026, under the existing ticker symbol NICO...
KEYCORP DECLARES QUARTERLY CASH DIVIDEND ON COMMON SHARES AND PREFERRED STOCKS
CLEVELAND, Nov. 12, 2026 /PRNewswire/ -- KeyCorp (NYSE: KEY) announced today that its Board of Directors declared the following dividends for the fourth quarter of 2026: A cash dividend of $0.205 per share on the corporation's outstanding common shares (NYSE: KEY). The dividend is payable on December 15, 2026, to holders of record of such Common Shares as of the close of business on December 1, 2026; A dividend of $15.3125 per share (equivalent to $.382813 per depositary share (NYSE: KEY.I)) on the corporation's outstanding Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock, Series E (CUSIP #493267801), payable on December 15, 2026 to holders of record as of the close of business on November 30, 2026, for the period commencing on (and including) September 15, 2026 to (but excluding) December 15, 2026; A dividend of $14.1250 per share (equivalent to $.353125 per depositary share (NYSE: KEY.J)) on the corporation's outstanding Fixed Rate Perpetual Non-Cumulative Preferred Stock, Series F (CUSIP #493267884), payable on December 15, 2026 to holders of record as of the close of business on November 30, 2026, for the period commencing on (and including) September 15, 2026 to (but excluding) December 15, 2026; A dividend of $14.0625 per share (equivalent to $.351563 per depositary share (NYSE: KEY.K)) on the corporation's outstanding Fixed Rate Perpetual Non-Cumulative Preferred Stock, Series G (CUSIP #493267850), payable on December 15, 2026 to holders of record as of the close of business on November 30, 2026, for the period commencing on (and including) September 15, 2026 to (but excluding) December 15, 2026; and A dividend of $15.50 per share (equivalent to $.3875 per depositary share (NYSE: KEY.L)) on the corporation's outstanding Fixed Rate Reset Perpetual Non-Cumulative Preferred Stock, Series H (CUSIP #493267835), payable on December 15, 2026 to holders of record as of the close of business on November 30, 2026, for the period commencing on (and including) September 15, 2026 to (but excluding) December 15, 2026...
Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
— Following positive NEXICART-2 clinical update, commercial launch preparation continues with commercial site activation activities, strengthened team, and provider and payer engagement —
Royalty Pharma to present at the UBS Global Biopharma Conference
NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the UBS Global Biopharma Conference on Tuesday, November 17, 2026 at 5:40 a.m. ET / 10:40 a.m. GMT.
John B. Sanfilippo & Son, Inc. Announces Share Repurchase Program and Special Dividend
Elgin, IL, Nov. 12, 2026 (GLOBE NEWSWIRE) -- John B. Sanfilippo & Son, Inc. Announces Share Repurchase Program and Special Dividend
NeoVolta Reports Financial Results for Quarter Ended September 30, 2026
Residential revenue rebounds sequentially, supported by initial third-party ownership platform activity Pendergrass manufacturing facility ramp on schedule Utility-scale $116M Master Purchase Agreement for products built at the Georgia facility with deliveries anchoring the plant's 2027 production ramp SAN DIEGO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- NeoVolta Inc. (NASDAQ: NEOV) (“NeoVolta” or the “Company”), a U.S.-based energy technology company delivering scalable energy storage solutions, today announced financial results for the quarter ended September 30, 2026. Quarter Ended September 30, 2026 Financial Highlights Revenue was $2.8 million, compared to approximately $13.5 thousand in the previous quarter ended June 30, 2026...
Enovis to Present at the Annual Jefferies Global Healthcare Concerence in London
Dallas, TX, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced that members of the Enovis management team will be presenting at the Annual Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, at 11:30 a.m. GMT (6:30 a.m. ET)...
Crescent Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Completed dose escalation in Phase 1/2 ASCEND trial of CR-001 with more than 125 patients dosed across United States, Europe and South Korea; enrolling standard of care chemotherapy combination expansion cohorts; on track for initial monotherapy data, including antitumor response for first-line non-small cell lung cancer (NSCLC) cohort in Q1 2027
United Community Banks, Inc. Announces Quarterly Cash Dividend on Common Stock
GREENVILLE, S.C., Nov. 12, 2026 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (the “Company”) reported that its Board of Directors approved a quarterly cash dividend of $0.26 per share on the Company's common stock. The dividend is payable on January 5, 2027, to shareholders of record as of December 15, 2026...
Innventure Reports Third Quarter 2026 Results
Company advances strategic repositioning through substantial cost reductions and disciplined capital allocation, with resources focused on preserving and maximizing the value of its interest in Accelsius Company advances strategic repositioning through substantial cost reductions and disciplined capital allocation, with resources focused on preserving and maximizing the value of its interest in Accelsius
Ardent Health Announces Definitive Agreement to Acquire Boone Health
BRENTWOOD, Tenn. & COLUMBIA, Mo.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced a definitive agreement to acquire Boone Health, a not-for-profit health system based in Columbia, Missouri, for a purchase price of $47 million in cash. The acquisition will include the 392-bed Boone Hospital Center, Boone Health Medical Group, 19 sites of care, related ancillary services and associated real estate...
The RMR Group Inc. Announces Fiscal Fourth Quarter 2026 Results
NEWTON, Mass.--(BUSINESS WIRE)--The RMR Group Inc. (Nasdaq: RMR) today announced its financial results for the fiscal quarter ended September 30, 2026, which can be found at the Quarterly Results section of RMR's website at https://www.rmrgroup.com/investors-and-media/financial-information/default.aspx. A conference call to discuss RMR's fiscal fourth quarter results will be held on Friday, November 13, 2026 at 11:00 a.m. Eastern Time. The conference call may be accessed by dialing (844) 481-29...
LSI Industries to Introduce Category of One Strategic Plan at Virtual Investor Event
CINCINNATI--(BUSINESS WIRE)--LSI Industries Inc. (Nasdaq: LYTS, “LSI” or the “Company”), a leading U.S.-based manufacturer of commercial lighting and display solutions, today announced that it will host a virtual investor event on Tuesday, December 15, 2026, at 11:00 a.m. ET to introduce Category of One, the next phase of the Company's multi-year value creation roadmap. Presentation materials will be available in the Investor Relations section of the Company's website at www.lsicorp.com prior t...
QXO Reports Third Quarter 2026 Results
GREENWICH, Conn.--(BUSINESS WIRE)--QXO, Inc. (“QXO” or the “Company”) (NYSE: QXO) today reported financial results for the third quarter of 2026. For the three months ended September 30, 2026, basic and diluted loss per common share was $(0.17). Adjusted Diluted Earnings per Common Share, a non-GAAP financial measure, was $0.13. Note: The following summary of financial results for the three and nine months ended September 30, 2026, includes the legacy Kodiak Building Partners, Inc. (“Kodiak”) o...
News Corp to Participate in the Morgan Stanley European Technology, Media & Telecom Conference
NEW YORK--(BUSINESS WIRE)--News Corp announced today that Chief Executive Robert Thomson will participate in the Morgan Stanley European Technology, Media & Telecom Conference in Barcelona on Thursday, November 19, 2026. The session will run from 5:00 AM to 5:45 AM EST (11:00 AM to 11:45 AM CET). To listen to the live webcast, please visit the News Corp website at https://investors.newscorp.com/calendar-events. A replay of the webcast is expected to be available at the same location for a p...
GrabAGun Appoints W. Bryan Hill to Board of Directors
COPPELL, Texas--(BUSINESS WIRE)--GrabAGun Digital Holdings Inc. (“GrabAGun” or the “Company”) (NYSE: PEW), a technology-driven commerce and platform company serving the firearms, ammunition and outdoor industry, today announced the appointment of W. Bryan Hill to its Board of Directors, effective November 9, 2026. Mr. Hill's appointment further strengthens the Board's public-company, financial and strategic expertise...
Martin Marietta Declares Quarterly Cash Dividend
RALEIGH, N.C., Nov. 12, 2026 (GLOBE NEWSWIRE) -- The board of directors of Martin Marietta Materials, Inc. (NYSE: MLM) (“Martin Marietta” or the “Company”) today declared a regular quarterly cash dividend of $0.84 per share on the Company's outstanding common stock. This dividend will be payable on December 31, 2026, to shareholders of record at the close of business on December 1, 2026...
Inuvo Third Quarter 2026 Results Reflect Inflection Point as IntentKey Pipeline Builds
IntentKey's Privacy-By-Design Value Proposition Resonates as Sales Pipeline Builds Legacy Search Revenue Stabilizes Management to host conference call at 4:15 PM ET, Thursday, November 12, 2026 LITTLE ROCK, Ark., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a provider of artificial intelligence-driven solutions for modeling media audiences, today announced financial results for the third quarter and nine months ended September 30, 2026, and provided a business update...
StoneCo Reports Third Quarter 2026 Results
George Town, Grand Cayman--(Newsfile Corp. - November 12, 2026) - StoneCo Ltd. (NASDAQ: STNE) ("Stone" or the "Company") today reported its financial results for the third quarter ended September 30, 2026, in an Earnings Release which is now posted to the company's Investor Relations website https://investors.stone.co/...
Atrium Therapeutics Reports Third Quarter 2026 Financial Results
-- First patient dosed with ATR 1072 in the Corventis™ Phase 1/2 clinical trial in PRKAG2 syndrome -- -- Nonclinical data showed ATR 1072 reversed cardiac glycogen accumulation and improved features of PRKAG2 syndrome -- -- Pro-forma cash balance at the end of September 2026 was $293.6 million with anticipated cash runway through 2028 -- SAN DIEGO, Nov. 12, 2026 /PRNewswire/ -- / PRNewswire/ – Atrium Therapeutics, Inc. (Nasdaq: RNA) ("Atrium," "Atrium Therapeutics," or the "Company"), a biopharmaceutical company advancing precision cardiology by developing RNA therapeutics targeted to the heart, today reported financial results for the third quarter ended September 30, 2026, and highlighted recent progress including dosing of the first patient in Corventis, its Phase 1/2 clinical trial of ATR 1072 in PRKAG2 syndrome, nonclinical data showing ATR 1072 reversed cardiac glycogen accumulation, and a $50 million private placement that extends its cash runway through 2028. "The last eight months have marked many firsts for Atrium, building toward our transition to a clinical stage company with the initiation of Corventis, the first clinical trial ever to target the root cause of PRKAG2 syndrome," said Kathleen Gallagher, President and Chief Executive Officer of Atrium Therapeutics...
VolitionRx Limited Announces Third Quarter 2026 Financial Results and Business Update
Conference call to discuss financial and operational results scheduled for Friday, November 13 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev.
Forward Industries Partners with Groma to Bring Tokenized Real Estate to Solana
Forward to Take Strategic Allocation in GromaCoin (GRO) Ahead of Its Planned Q1 2027 Solana Launch
Sanara MedTech Inc. Reports Third Quarter 2026 Financial Results (Unaudited)
FORT WORTH, TX, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today reported its financial results for the third quarter ended September 30, 2026...
Adams Diversified Equity Fund Declares Distribution
BALTIMORE, Nov. 12, 2026 (GLOBE NEWSWIRE) -- On November 12, 2026, Adams Diversified Equity Fund, Inc. (NYSE: ADX) declared a distribution of $0.56 per share payable December 23, 2026 to shareholders of record on November 20, 2026. The distribution is optionally payable in additional shares of common stock (default) or in cash by specific stockholder election received before 4 p.m. (ET) on December 10, 2026, the valuation date. The issue price for shares will be the lower of the Fund's closing NYSE market price or the Fund's NAV per share on the valuation date, but in no event less than 95% of the NYSE closing market price...
MediaAlpha Announces $16 Million Private Stock Repurchase
LOS ANGELES, Nov. 12, 2026 (GLOBE NEWSWIRE) -- MediaAlpha, Inc. (NYSE: MAX), the insurance industry's leading programmatic customer acquisition platform, today announced that it has repurchased 1.13 million shares of its Class A common stock from an affiliate of White Mountains Insurance Group, Ltd. (NYSE: WTM) for approximately $16.0 million...
Adams Natural Resources Fund Declares Distribution
BALTIMORE, Nov. 12, 2026 (GLOBE NEWSWIRE) -- On November 12, 2026, Adams Natural Resources Fund, Inc. (NYSE: PEO) declared a distribution of $0.84 per share payable December 21, 2026 to shareholders of record on November 20, 2026. The distribution is optionally payable in additional shares of common stock (default) or in cash by specific stockholder election received before 4 p.m. (ET) on December 10, 2026, the valuation date. The issue price for shares will be the lower of the Fund's closing NYSE market price or the Fund's NAV per share on the valuation date, but in no event less than 95% of the NYSE closing market price...
OptimumBank Holdings, Inc. Financial Performance for the Third Quarter of 2026
Fort Lauderdale, FL, Nov. 12, 2026 (GLOBE NEWSWIRE) -- OptimumBank Holdings, Inc. (NYSE American: OPHC) (the “Company”) is a financial holding company and owns 100% of OptimumBank (the “Bank”), a Florida-chartered commercial bank, OptimumHUD Loans, LLC (d/b/a OptimumFunding, LLC), a wholly owned non-bank Bridge and HUD-lender and OptimumFinance, LLC, a non-bank, wholly owned financing subsidiary...
ProKidney Reports Third Quarter 2026 Financial Results and Business Highlights
WINSTON-SALEM, N.C., Nov. 12, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cell therapy company focused on chronic kidney disease (CKD), today reported financial results for the third quarter ended September 30, 2026 and provided business highlights and upcoming milestones...